CAS No. : 936563-96-1

(Synonyms: Ibrutinib)

Price and Availability of CAS No. : 936563-96-1
Size Price Stock
10mg $60 In-stock
50mg $84 In-stock
100mg $108 In-stock
200mg $132 In-stock
500mg $228 In-stock
1g $348 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via sales@chemexpress.cn

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-10997
M.Wt: 440.50
Formula: C25H24N6O2
Purity: >98 %
Storage: at 20℃ 2 years
Solubility: DMSO: ≥ 52 mg/mL
Introduction of 936563-96-1 :

PCI-32765 is a selective, irreversible Btk inhibitor with IC50 value of 0.5 nM. IC50 & Target: IC50: 0.5 nM (Btk) In Vitro: PCI-32765 selectively inhibits B-cell signaling and activation. It inhibits autophosphorylation of Btk (IC50=11 nM), phosphorylation of Btk's physiological substrate PLCγ (IC50=29 nM), and phosphorylation of a further downstream kinase, ERK (IC50=13 nM)[1]. PCI-32765 inhibits BCR-activated primary B cell proliferation (IC50=8 nM). Following FcγR stimulation, PCI-32765 inhibits TNFα, IL-1β and IL-6 production in primary monocytes (IC50=2.6, 0.5, 3.9 nM, respectively)[3]. In Vivo: PCI-32765 (3.125-50 mg/kg, p.o.) reduces the level of circulating autoantibodies and completely suppresses disease in mice with collagen-induced arthritis. PCI-32765 inhibits autoantibody production and the development of kidney disease in the MRL-Fas(lpr) lupus model. PCI-32765 (3.125-50 mg/kg, p.o.) reduces renal disease and autoantibody production in MRL-Fas(lpr) mice[1]. PCI-32765 (0.1 μM) inhibits activation-induced proliferation of CLL cells, induces selective cytotoxicity in B cells compared with T cells, but alters activation induced T-cell cytokine production[2]. PCI-32765 dose-dependently and potently reverses arthritic inflammation in a therapeutic CIA model with an ED50 of 2.6 mg/kg/day. PCI-32765 also prevents clinical arthritis in CAIA models[3].

Your information is safe with us.